ArticleAging and disease2025
Aging as a Networked Process: Systems, Signals, and Interventions Across the Lifespan.
Article in Aging and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Comment on
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As global populations age, chronic disease burden rises across multiple organ systems. This special issue treats aging as a multi-system process shaped by biology, environment, and behavior. Across 30 original studies and reviews, the collection centers on shared mechanisms of decline, including mitochondrial dysfunction, circadian disruption, hypoxia, inter-organ signaling, and cellular senescence. The articles track how these processes change across tissues and across time. Multiple contributions link systemic changes to tissue-level dysfunction. Vascular, immune, and metabolic shifts appear repeatedly as upstream drivers. The issue also emphasizes local context. Tissue microenvironments shape how the same systemic stressor produces different outcomes, which helps explain heterogeneity in aging trajectories. Several papers move toward translation. They propose biomarkers and diagnostic strategies aimed at earlier detection, risk stratification, and longitudinal monitoring. The strongest translational value comes when authors connect a proposed tool to a defined endpoint and a defined use case, rather than broad "precision" framing. Overall, the issue argues for tighter alignment between mechanism and measurable outcomes. The collection also highlights critical areas where further validation and integration are needed to support clinical translation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.